Official SEC submissions

Ernexa Therapeutics SEC Filings

Direct answer

Ernexa Therapeutics's latest SEC filing is 8-K.

It was filed on October 15, 2026, and 40 recent filings are available.

Each row links directly to the SEC document and filing index.

Official SEC EDGAR submissions

Get free Ernexa Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

8-K

Current report

Filed: 2026-10-15

Report date: 2026-10-15

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-09-16

Report date: 2026-09-16

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-09-16

Report date: 2026-09-14

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-09-01

Report date: 2026-08-31

Open SEC document View filing index

Insider transaction

Filed: 2026-09-01

Report date: 2026-08-31

Open SEC document View filing index

Insider transaction

Filed: 2026-09-01

Report date: 2026-08-31

Open SEC document View filing index

Insider transaction

Filed: 2026-09-01

Report date: 2026-08-31

Open SEC document View filing index

Insider transaction

Filed: 2026-09-01

Report date: 2026-08-31

Open SEC document View filing index

Insider transaction

Filed: 2026-09-01

Report date: 2026-08-31

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-08-06

Report date: 2026-06-30

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-07-02

Report date: 2026-07-02

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-07-02

Report date: 2026-07-01

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-06-26

Report date: 2026-06-22

8-K

Open SEC document View filing index

DEFA14A

Proxy statement

Filed: 2026-05-11

DEFA14A

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2026-05-11

Report date: 2026-05-11

DEF 14A

Open SEC document View filing index

10-Q

Periodic report

Filed: 2026-05-11

Report date: 2026-03-31

10-Q

Open SEC document View filing index

8-K

Current report

Filed: 2026-05-04

Report date: 2026-05-01

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-03-20

Report date: 2026-03-18

8-K

Open SEC document View filing index

10-K

Periodic report

Filed: 2026-03-13

Report date: 2025-12-31

10-K

Open SEC document View filing index

8-K

Current report

Filed: 2026-02-26

Report date: 2026-02-26

8-K

Open SEC document View filing index

Insider transaction

Filed: 2026-02-17

Report date: 2026-02-10

OWNERSHIP DOCUMENT

Open SEC document View filing index

8-K

Current report

Filed: 2026-02-11

Report date: 2026-02-06

8-K

Open SEC document View filing index

S-1/A

Registration statement

Filed: 2026-02-05

S-1/A

Open SEC document View filing index

S-1/A

Registration statement

Filed: 2026-02-04

S-1/A

Open SEC document View filing index

S-1

Registration statement

Filed: 2026-02-03

S-1

Open SEC document View filing index

8-K

Current report

Filed: 2025-12-11

Report date: 2025-12-11

8-K

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-11-07

Report date: 2025-09-30

10-Q

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-08-13

Report date: 2025-06-30

10-Q

Open SEC document View filing index

Insider transaction

Filed: 2025-07-07

Report date: 2025-06-21

Open SEC document View filing index

8-K

Current report

Filed: 2025-07-07

Report date: 2025-06-30

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-06-12

Report date: 2025-06-12

8-K

Open SEC document View filing index

Insider transaction

Filed: 2025-06-11

Report date: 2025-06-09

OWNERSHIP DOCUMENT

Open SEC document View filing index

8-K

Current report

Filed: 2025-06-09

Report date: 2025-06-09

8-K

Open SEC document View filing index

8-K

Current report

Filed: 2025-06-02

Report date: 2025-06-02

8-K

Open SEC document View filing index

10-Q

Periodic report

Filed: 2025-05-07

Report date: 2025-03-31

10-Q

Open SEC document View filing index

4/A

Insider transaction

Filed: 2025-05-07

Report date: 2024-09-24

OWNERSHIP DOCUMENT

Open SEC document View filing index

DEF 14A

Proxy statement

Filed: 2025-04-14

Report date: 2024-12-31

Open SEC document View filing index

Insider transaction

Filed: 2025-04-04

Report date: 2025-04-02

OWNERSHIP DOCUMENT

Open SEC document View filing index

8-K

Current report

Filed: 2025-04-03

Report date: 2025-03-31

Open SEC document View filing index

8-K

Current report

Filed: 2025-03-26

Report date: 2025-03-26

Open SEC document View filing index

Verified data

Recent filing categories: 5
Recent filings: 40
SEC CIK: 0000748592
Latest filing date: October 15, 2026

Explore related company data

View the Ernexa Therapeutics company profile View Ernexa Therapeutics annual financials